Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olevia for prevention of postoperative atrial fibrillation after heart valve surgery
2016-002956-25Phase 2Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of omega-3-acid ethyl esters in Atrial fibrillation (AFib) and Cardiac valve disease (VHD), sponsored by Policlinico Gemelli. Primary endpoint: Incidence of postoperative atrial fibrillation. Started Oct 2020; status: terminated.
02
Drugs
omega-3-acid ethyl esters
03
Conditions
Atrial fibrillation (AFib)Cardiac valve disease (VHD)
Beyond the preview
Go deeper on 2016-002956-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002956-25.